Single-Cycle SIV Vaccine Reduces Viral Loads in Rhesus Macaques
Author Information
Author(s): Jia Bin, Ng Sharon K., DeGottardi M. Quinn, Piatak Michael Jr., Yuste Eloísa, Carville Angela, Mansfield Keith G., Li Wenjun, Richardson Barbra A., Lifson Jeffrey D., Evans David T.
Primary Institution: Harvard Medical School, New England Primate Research Center
Hypothesis
Can immunization with single-cycle SIV provide protective immunity against wild-type SIVmac239 infection?
Conclusion
Immunization with single-cycle SIV significantly reduced viral loads and preserved memory CD4+ T cell counts after SIVmac239 challenge.
Supporting Evidence
- Both immunization regimens resulted in statistically significant reductions in viral loads.
- Immunized animals had better preservation of memory CD4+ T cell subsets compared to controls.
- The study suggests ongoing stimulation of virus-specific immune responses may be essential for effective vaccination.
Takeaway
Researchers tested a new vaccine using a modified virus that only infects cells once, and it helped monkeys fight off a similar virus better than those who didn't get the vaccine.
Methodology
Rhesus macaques were immunized with single-cycle SIV using two different regimens and then challenged with SIVmac239 to assess viral load and immune response.
Potential Biases
Potential genetic differences among macaques may influence immune response outcomes.
Limitations
The extent of protection was not as good as that achieved by live, attenuated SIV vaccines.
Participant Demographics
Indian origin rhesus macaques (Macaca mulatta).
Statistical Information
P-Value
p=0.005 for peak viral loads in Group A
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website